• Column: Five Reasons the Gilead Deal is a Steaming Pile of Truvada

    Gilead Sciences, the pharmaceutical company that makes Truvada, the only FDA-approved drug for PrEP, is having a great week in the public relations department. First, Gilead announced they were surrendering their patent for Truvada a year early, and now federal officials have announced that Gilead will donate enough Truvada for 200,000 people in the United States.

  • Gilead Hit With More Lawsuits Over Harmful Side Effects of AIDS Drug

    (WB) Another two lawsuits were filed last week in California against the U.S. pharmaceutical company Gilead Sciences, Inc. by several dozen patients who claim the company withheld from the market for more than a decade a drug for treating HIV that it knew was safer and more effective than the drug it promoted during that period.

  • Gilead Sued for HIV-related Privacy Invasions

    (EPGN) Gilead Sciences Inc., a biopharmaceutical company based in Foster City, California, was recently sued for allegedly violating HIV-privacy rights when sending out a mass mailing to customers using envelopes linking them to HIV-related medications.